John Simard

Insider Reports History

Reporting-owner location: Austin, TX
Latest reporting-owner signature: John Simard
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Simard

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

XBiotech Inc.

Security class: Convertible Loan Agreement
Shares / value: 3,840,736
Estimated value
Report date: 03 Jan 2024
Price
Ownership: Direct
Underlying class: Common Shares or Preferred Shares
Underlying amount

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

XBiotech Inc.

Security class: Stock Option
Shares / value: 1,896,609
Estimated value
Report date: 17 Mar 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by John Simard

4 XBIT

XBiotech Inc.

Report period: 17 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Mar 2025, 15:03
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 31 Jan 2025
Transactions: 1
Transaction value: -$24,703,550,000,000
Accepted by SEC: 04 Feb 2025, 16:53
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 03 Jan 2024
Transactions: 1
Transaction value: +$24,703,550,000,000
Accepted by SEC: 05 Jan 2024, 10:48
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 15 Oct 2021
Transactions: 2
Transaction value: -$657,724
Accepted by SEC: 15 Feb 2022, 15:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 07 Oct 2021
Transactions: 4
Transaction value: -$1,131,099
Accepted by SEC: 15 Oct 2021, 12:26
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 04 Oct 2021
Transactions: 3
Transaction value: -$624,181
Accepted by SEC: 06 Oct 2021, 17:48
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 28 Sep 2021
Transactions: 4
Transaction value: -$812,117
Accepted by SEC: 01 Oct 2021, 16:39
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 23 Sep 2021
Transactions: 3
Transaction value: -$753,419
Accepted by SEC: 28 Sep 2021, 10:59
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 20 Sep 2021
Transactions: 3
Transaction value: -$757,584
Accepted by SEC: 22 Sep 2021, 18:12
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 XBIT

XBiotech Inc.

Report period: 14 Jul 2021
Transactions: 1
Transaction value: -$907,350
Accepted by SEC: 19 Jul 2021, 14:27
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .